Home › NDC Lookup › RxCUI directory › RxCUI 2691839

Dasatinib 140 MG Oral Tablet [Phyrago] — RxCUI 2691839

RxNorm drug concept · Semantic branded drug
RxCUI 2691839 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2691839
Official nameDasatinib 140 MG Oral Tablet [Phyrago]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPhyrago 140 MG Oral Tablet
FDA products mapped6
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dasatinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dasatinib targets a specific abnormal protein called BCR-ABL, which is produced by the Philadelphia chromosome — a genetic mutation that drives your type of leukemia. By blocking B...
  • What exactly is dasatinib treating — what does it do to my leukemia?
  • You have flexibility here — dasatinib can be taken with or without food, and you can take it in the morning or evening, whichever fits your routine. The most important things are t...
  • Does it matter when I take it or whether I eat first?
📖 Read our full Dasatinib guide →

🕸️ Concept Web — How Dasatinib 140 MG Oral Tablet [Phyrago] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dasatinib 140 MG Oral Tablet [Phyrago] RxCUI 2691839

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dasatinib 475342
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Phyrago 2691832
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dasatinib Oral Tablet 643104
    • Dasatinib Oral Product 1157186
    • Dasatinib Pill 1157187
    • Dasatinib Oral Tablet [Phyrago] 2691836
    • Phyrago Oral Product 2691834
    • Phyrago Pill 2691835
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dasatinib 140 MG Oral Tablet SCD · 1045402
  • Dasatinib 140 MG SCDC · 1045401
  • Dasatinib Oral Tablet SCDF · 643104
  • Dasatinib Oral Product SCDG · 1157186
  • Dasatinib Pill SCDG · 1157187

Brand-Name Concepts

  • Dasatinib 140 MG [Phyrago] SBDC · 2691838
  • Dasatinib Oral Tablet [Phyrago] SBDF · 2691836
  • Phyrago Oral Product SBDG · 2691834
  • Phyrago Pill SBDG · 2691835
  • Phyrago BN · 2691832

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 2691839 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70709-0151-20 60 TABLET in 1 BOTTLE (70709-151-20) PHYRAGO Cycle Pharmaceuticals Ltd 2025-09-22
70709-0152-50 60 TABLET in 1 BOTTLE (70709-152-50) PHYRAGO Cycle Pharmaceuticals Ltd 2025-09-22
70709-0153-70 60 TABLET in 1 BOTTLE (70709-153-70) PHYRAGO Cycle Pharmaceuticals Ltd 2025-09-22
70709-0154-80 30 TABLET in 1 BOTTLE (70709-154-80) PHYRAGO Cycle Pharmaceuticals Ltd 2025-09-22
70709-0155-10 30 TABLET in 1 BOTTLE (70709-155-10) PHYRAGO Cycle Pharmaceuticals Ltd 2025-09-22
70709-0156-14 30 TABLET in 1 BOTTLE (70709-156-14) PHYRAGO Cycle Pharmaceuticals Ltd 2025-09-22
Observed labelers: Cycle Pharmaceuticals Ltd (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.